Secondary malignant neoplasms in patients with bladder carcinoma.
At the University of Pennsylvania and its affiliates, 292 patients with bladder carcinoma treated with a variety of definitive regimens were observed for the incidence of secondary malignancies. The cumulative incidence at fifty-four months, including synchronous primary neoplasms, was 24 percent. Hazard function analysis reveals a relatively constant risk of new neoplasms to be approximately 1.5 percent per year over a period of forty-eight months after diagnosis.
Greven
K M
KM
Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia.
Spera
J A
JA
Solin
L J
LJ
Whittington
R
R
Wein
A J
AJ
Hanks
G E
GE
D006801:Humans; D015994:Incidence; D016609:Neoplasms, Second Primary / Q000453:epidemiology*; D016016:Proportional Hazards Models; D001749:Urinary Bladder Neoplasms / Q000473:pathology*